<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04927156</url>
  </required_header>
  <id_info>
    <org_study_id>CIP-202002-BALT DEVICES</org_study_id>
    <nct_id>NCT04927156</nct_id>
  </id_info>
  <brief_title>Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform</brief_title>
  <official_title>Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform. An International, Multicenter, Prospective, and Retrospective Data Collection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balt Extrusion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Balt Extrusion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      BALT has designed an electronic platform to continue collecting clinical data as part of the&#xD;
      post-marketing clinical follow-up of its devices.&#xD;
&#xD;
      This platform is purely exploratory, without hierarchical order of the objectives and&#xD;
      associated outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 12, 2021</start_date>
  <completion_date type="Anticipated">October 2041</completion_date>
  <primary_completion_date type="Anticipated">June 2041</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of occurrence of device-specific safety indicator(s).</measure>
    <time_frame>From the procedure to 12 months post-procedure depending on the device family.</time_frame>
    <description>Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of devices achieving its intended use.</measure>
    <time_frame>From the procedure to 12 months post-procedure depending on the device family.</time_frame>
    <description>Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of devices achieving its specific performance indicator(s).</measure>
    <time_frame>From the procedure to 12 months post-procedure depending on the device family.</time_frame>
    <description>Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of devices in each category of the usability scale (Likert-type scale) for each usability indicator</measure>
    <time_frame>From the procedure to 12 months post-procedure depending on the device family.</time_frame>
    <description>Qualitative measurement of usability for each usability indicator (i.e., good, well adapted, fairly adapted, bad). Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <condition>Brain Arterial Disease</condition>
  <condition>Acute Ischemic Stroke</condition>
  <condition>Peripheral Vascular Diseases</condition>
  <arm_group>
    <arm_group_label>BALT medical devices</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BALT medical devices</intervention_name>
    <description>Includes, but is not limited to, the following:&#xD;
Access devices&#xD;
Aneurysm treatment devices&#xD;
Ischemic Stroke and peripheral occlusive diseases treatment devices&#xD;
Arterio-Venous Malformations/fistulas treatment devices</description>
    <arm_group_label>BALT medical devices</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will include the BALT medical devices under consideration used in&#xD;
        their respective indications for use during interventions performed at the participating&#xD;
        sites.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provision of a signed, written and dated informed consent or non-opposition (where&#xD;
             applicable)&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Device(s) used in multiple procedures (two, or more, pathologies treated during the&#xD;
             same procedure)&#xD;
&#xD;
          -  Contra-indications of each device as described in the instructions for use.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clinical Affairs Department</last_name>
    <phone>+33 1 39 89 46 41</phone>
    <email>Evidence@baltgroup.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Anne PASCO PAPON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble Alpes</name>
      <address>
        <city>La Tronche</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kamel Boubagra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Roger Salengro</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Nicolas Bricout, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de cruces</name>
      <address>
        <city>Baracaldo</city>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Alexander Aguinaga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital: Fundacion Jimenez Diaz</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Eduardo Crespo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudio Rodriguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital: Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Aurelio Vega, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rocio Gonzalez Costero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unversitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Pedro Vega, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla (HUMV)</name>
      <address>
        <city>Santander</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Andrés Gonzalez Mandly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Santiago Guelbenzu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joaquin Medrano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 9, 2021</study_first_submitted>
  <study_first_submitted_qc>June 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Intracranial Arterial Diseases</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

